Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and MTD (maximum tolerated
dose) of TTI-237 for the treatment of subjects with advanced malignant solid tumors.